series-b
Stage
2020
Founded
1
Investors
About
Rivermark Medical is a urology-focused medical device company committed to redefining benign prostatic hyperplasia (BPH) treatment through simple, innovative solutions. The company developed the FloStent system, a minimally invasive device designed to treat BPH symptoms by restoring normal urinary flow during routine cystoscopy procedures.
Explore Rivermark Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.